tiprankstipranks
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
2796
Pharmarise Holdings Corp.
RESEARCH TOOLSreports

Pharmarise Holdings Corp. (2796) Financial Statements

0 Followers

Pharmarise Holdings Corp. Financial Overview

Pharmarise Holdings Corp.'s market cap is currently ¥6.12B. The company's EPS TTM is ¥13.7; its P/E ratio is -12.09; and it has a dividend yield of 2.65%. Pharmarise Holdings Corp. is scheduled to report earnings on April 1, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
May 24May 23May 22May 21May 20
Income Statement
Total Revenue¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B¥ 51.03B
Gross Profit¥ 8.20B¥ 7.89B¥ 7.50B¥ 7.42B¥ 6.73B
Operating Income¥ 295.00M¥ 916.00M¥ 1.44B¥ 1.52B¥ 997.00M
EBITDA¥ 1.79B¥ 2.09B¥ 2.66B¥ 2.83B¥ 2.23B
Net Income¥ -368.00M¥ -351.00M¥ 333.00M¥ 448.00M¥ 577.00M
Balance Sheet
Cash & Short-Term Investments¥ 4.91B¥ 7.15B¥ 4.74B¥ 3.99B¥ 4.47B
Total Assets¥ 31.99B¥ 29.54B¥ 23.46B¥ 23.78B¥ 25.21B
Total Debt¥ 14.28B¥ 12.75B¥ 9.14B¥ 9.91B¥ 11.23B
Net Debt¥ 9.39B¥ 5.65B¥ 4.40B¥ 5.92B¥ 6.76B
Total Liabilities¥ 25.07B¥ 22.10B¥ 16.47B¥ 17.08B¥ 19.26B
Stockholders' Equity¥ 6.87B¥ 7.36B¥ 6.88B¥ 6.61B¥ 5.91B
Cash Flow
Free Cash Flow¥ 674.00M¥ 2.24B¥ 2.14B¥ 334.00M¥ 1.22B
Operating Cash Flow¥ 1.31B¥ 2.71B¥ 2.52B¥ 713.00M¥ 1.57B
Investing Cash Flow¥ -4.46B¥ -3.12B¥ -703.00M¥ -292.00M¥ -734.00M
Financing Cash Flow¥ 939.00M¥ 2.77B¥ -1.07B¥ -1.03B¥ -766.00M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

Income Statement >

Pharmarise Holdings Corp. Debt to Assets

Balance Sheet >

Pharmarise Holdings Corp. Cash Flow

Cash Flow >

Pharmarise Holdings Corp. Forecast EPS vs Actual EPS

Earnings >